Estrella Immunopharma Inc (ESLA)

$2.38 +0.05 (2.15%)
Market Cap 86.36M
Revenue (ttm) 0.00
Net Income (ttm) -7.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 812,200
Avg Vol 166,810
Day's Range N/A - N/A
Shares Out 37.07M
Stochastic %K 84%
Beta 0.39
Analysts Strong Sell
Price Target $16.00

Company Profile

Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a coll...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 318 9098
Address:
5858 Horton Street, Suite 370, EmeryVille, United States
Stocksiren
Stocksiren Oct. 24 at 3:34 PM
$ESLA
0 · Reply
StockScanners
StockScanners Oct. 24 at 12:50 AM
$ESLA reached 2.37
0 · Reply
Stocksiren
Stocksiren Oct. 23 at 11:18 AM
$ESLA
0 · Reply
StockScanners
StockScanners Oct. 23 at 12:48 AM
$ESLA keep watch if this holds above 2.15
0 · Reply
MoEx
MoEx Oct. 22 at 9:53 PM
My list $AREB $APLT $ESLA $CCO 👌✅ wait and watch !
0 · Reply
Stocksiren
Stocksiren Oct. 22 at 6:54 PM
$ESLA
0 · Reply
MarketMasterMind
MarketMasterMind Oct. 22 at 5:35 PM
$ESLA adding some 🤑Ⓜ️
0 · Reply
topstockalerts
topstockalerts Oct. 22 at 5:28 PM
$ESLA It is ready to run..
0 · Reply
AlGo88
AlGo88 Oct. 22 at 4:53 PM
$ESLA solid
0 · Reply
DaBullRunner
DaBullRunner Oct. 22 at 3:36 PM
$ESLA there it goes…… SCNX watching closely as this company is the only one I know trading under $1 with TWO FDA approved products 🚨🚨🚨
0 · Reply
Latest News on ESLA
Estrella Immunopharma Regains Compliance with Nasdaq Listing Requirements

Oct 6, 2025, 8:00 AM EDT - 19 days ago

Estrella Immunopharma Regains Compliance with Nasdaq Listing Requirements

Estrella Immunopharma Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin's Lymphoma

Jun 5, 2025, 8:00 AM EDT - 5 months ago

Estrella Immunopharma Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin's Lymphoma

Estrella Immunopharma Announces Approximately $3.35 Million Private Placement Equity Financing

Jun 3, 2025, 8:00 AM EDT - 5 months ago

Estrella Immunopharma Announces Approximately $3.35 Million Private Placement Equity Financing

Estrella Immunopharma Initiates Second Cohort and Doses First Patient in STARLIGHT-1 Trial of EB103 in Advanced B-Cell Non-Hodgkin's Lymphomas

May 29, 2025, 8:01 AM EDT - 5 months ago

Estrella Immunopharma Initiates Second Cohort and Doses First Patient in STARLIGHT-1 Trial of EB103 in Advanced B-Cell Non-Hodgkin's Lymphomas

Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Buy Rating With a Price Target of $14.00 From CB Capital Partners

Mar 5, 2025, 8:00 AM EST - 8 months ago

Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Buy Rating With a Price Target of $14.00 From CB Capital Partners

Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort

Feb 21, 2025, 8:30 AM EST - 8 months ago

Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital

Feb 19, 2025, 4:46 PM EST - 8 months ago

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital

Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells

Sep 27, 2024, 12:00 PM EDT - 1 year ago

Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

Aug 14, 2024, 12:00 PM EDT - 1 year ago

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

TradeUP Acquisition Corp. and Estrella Biopharma, Inc. Announce Completion of Business Combination

Sep 29, 2023, 10:34 AM EDT - 2 years ago

TradeUP Acquisition Corp. and Estrella Biopharma, Inc. Announce Completion of Business Combination

Estrella Immunopharma Nears Completion Of SPAC Listing

Sep 19, 2023, 1:30 AM EDT - 2 years ago

Estrella Immunopharma Nears Completion Of SPAC Listing

TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination

Sep 18, 2023, 5:00 PM EDT - 2 years ago

TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination

Estrella Biopharma, Inc., a biopharmaceutical company to Become a Publicly Traded Company Via Merger with TradeUP Acquisition Corp.

Oct 3, 2022, 7:27 AM EDT - 3 years ago

Estrella Biopharma, Inc., a biopharmaceutical company to Become a Publicly Traded Company Via Merger with TradeUP Acquisition Corp.

Stocksiren
Stocksiren Oct. 24 at 3:34 PM
$ESLA
0 · Reply
StockScanners
StockScanners Oct. 24 at 12:50 AM
$ESLA reached 2.37
0 · Reply
Stocksiren
Stocksiren Oct. 23 at 11:18 AM
$ESLA
0 · Reply
StockScanners
StockScanners Oct. 23 at 12:48 AM
$ESLA keep watch if this holds above 2.15
0 · Reply
MoEx
MoEx Oct. 22 at 9:53 PM
My list $AREB $APLT $ESLA $CCO 👌✅ wait and watch !
0 · Reply
Stocksiren
Stocksiren Oct. 22 at 6:54 PM
$ESLA
0 · Reply
MarketMasterMind
MarketMasterMind Oct. 22 at 5:35 PM
$ESLA adding some 🤑Ⓜ️
0 · Reply
topstockalerts
topstockalerts Oct. 22 at 5:28 PM
$ESLA It is ready to run..
0 · Reply
AlGo88
AlGo88 Oct. 22 at 4:53 PM
$ESLA solid
0 · Reply
DaBullRunner
DaBullRunner Oct. 22 at 3:36 PM
$ESLA there it goes…… SCNX watching closely as this company is the only one I know trading under $1 with TWO FDA approved products 🚨🚨🚨
0 · Reply
Soyaz
Soyaz Oct. 22 at 3:07 PM
$ESLA been riding this for a while with some gambling money...liking where this seems to be headed
0 · Reply
MoEx
MoEx Oct. 20 at 9:57 PM
$ESLA got a bag today 👌 bullish imo .
0 · Reply
StockHounding
StockHounding Oct. 18 at 4:29 PM
$BCG overlooked ipo Fits theme Didn't expect a move to over $3.20 yesterday All eyes here now $YCBD flagging $ROMA bullish $INTJ bottom again $ESLA creeping up
0 · Reply
Mercedes2017
Mercedes2017 Oct. 14 at 6:39 PM
$ESLA
0 · Reply
Colonia
Colonia Oct. 14 at 4:54 PM
$ESLA I'll try to sell mine at close to $10. Wish me well!
0 · Reply
AlGo88
AlGo88 Oct. 14 at 3:57 PM
$ESLA approaching 52-week high.
0 · Reply
AlGo88
AlGo88 Oct. 14 at 2:47 PM
$ESLA this hidden gem only has 295 watches…risk just became lower now that they have NASDAQ compliance. $SPRB $NVAX
0 · Reply
AlGo88
AlGo88 Oct. 14 at 2:41 PM
$ESLA volume has been picking up the last few months, consolidating really well. $2+ soon?
1 · Reply
Doozio
Doozio Oct. 13 at 10:13 PM
$TSLA $TLSA $ESLA 👀 MAMA. YO did say it’s gonna be LGNDary during 🐒🍌🧠⏰♾️ ❤️👑🌈🦄
0 · Reply
StockHounding
StockHounding Oct. 12 at 8:32 PM
$ELOG catching fire all over Massive hype Following the POST IPO hot stocks theme $GWAV and $OBIO up 10% $ESLA bounce?
0 · Reply
AlGo88
AlGo88 Oct. 6 at 2:55 PM
$ESLA regained NASDAQ compliance! Risk reward just got even better here. $SPRB
0 · Reply
MoEx
MoEx Oct. 2 at 9:42 AM
$ESLA I smell pump coming !
0 · Reply